On Invalid Date, Agios Pharmaceuticals (NASDAQ: AGIO) reported Q4 2023 earnings per share (EPS) of -$1.72, up 356.72% year over year. Total Agios Pharmaceuticals earnings for the quarter were -$95.94 million. In the same quarter last year, Agios Pharmaceuticals's earnings per share (EPS) was $0.67.
As of Q1 2024, Agios Pharmaceuticals's earnings has grown year over year. Agios Pharmaceuticals's earnings in the past year totalled -$352.09 million.
What is AGIO's earnings date?
Agios Pharmaceuticals's earnings date is Invalid Date. Add AGIO to your watchlist to be reminded of AGIO's next earnings announcement.
What was AGIO's revenue last quarter?
On Invalid Date, Agios Pharmaceuticals (NASDAQ: AGIO) reported Q4 2023 revenue of $7.10 million up 64.8% year over year. In the same quarter last year, Agios Pharmaceuticals's revenue was $4.31 million.
What was AGIO's revenue growth in the past year?
As of Q1 2024, Agios Pharmaceuticals's revenue has grown 88.36% year over year. This is 77.25 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Agios Pharmaceuticals's revenue in the past year totalled $26.82 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.